Literature DB >> 25033678

[Chemoradiotherapy for locally advanced cervical cancer].

I Ia Bazaeva, V A Gorbunova, O A Kravets, S V Khokhlova, S V Limareva, V O Panov, O N Strel'tsova, E V Tarachkova.   

Abstract

Cervical cancer takes second place in morbidity and third place in mortality from gynecological cancer. Advanced stages among newly diagnosed cases is still large. The "gold standard" of treatment for locally advanced cervical cancer is chemoradiotherapy with cisplatin that results in a lower risk of death. Improvement of radiotherapy methods allowed to bring optimal dose to the primary tumor with the inclusion of regional metastasis areas with less risk of damage to surrounding healthy tissue and organs. The search for alternative combinations of cytostatics, modes of drug administration, adjuvant chemotherapy after chemoradiotherapy showed an increase in survival of patients with locally advanced cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25033678

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  1 in total

1.  Expression of VEGF and HIF-1α in locally advanced cervical cancer: potential biomarkers for predicting preoperative radiochemotherapy sensitivity and prognosis.

Authors:  Pengfeng Zhu; Yangjun Ou; Yishan Dong; Peizhen Xu; Lei Yuan
Journal:  Onco Targets Ther       Date:  2016-05-23       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.